Molecular biologically, endometrial stromal sarcomas with BCOR rearrangement bear common MDM2 amplification and activation of the cyclin D1-CDK4 pathway by CDK4 amplification by cyclin D1 protein overexpression or CDKN2A deletion (25). The gene discussed is CDK4; the disease is endometrioid stromal sarcoma.